Tamsulin S FDC in LUTS/BPH: Patient Journeys & Evidence

This presentation delves into the relevance of Fixed-Dose Combination (FDC) therapy in the management of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH). It evaluates the current treatment landscape, highlighting patient-centric outcomes such as improved adherence and higher satisfaction rates, supported by key findings from a study. A case study from Poland demonstrates practical implementation and its impact on patient outcomes. From a pharmacist’s perspective, the...